Ecuador-Colombia Trade War Escalates to 50% Bilateral Tariffs on ~$2.8B in Annual Trade

Escalation Timeline

The bilateral trade dispute between Ecuador and Colombia has escalated rapidly since early February 2026:

Date	Action	Actor	Detail
Feb 1, 2026	30% "security tariff"	Ecuador	Applied to broad range of Colombian imports; justified as revenue measure for internal security operations
Feb 24, 2026	30% retaliatory tariff	Colombia	Matching tariff on Ecuadorian goods; President Petro cited "unjustified trade aggression"
Late Feb 2026	Electricity export suspension	Colombia	Indefinite halt of ~400-500 MW daily supply
Mar 1, 2026	Tariff raised to 50%	Ecuador	Escalation covering additional product categories
Mar (ongoing)	50% tariff on ~300 goods	Colombia	Matching Ecuador's escalation; formal WTO notification filed
Ongoing	OCP pipeline fee increase	Ecuador	Raised transport tariffs for OCP Ecuador S.A. pipeline

Bilateral Trade Profile

Ecuador-Colombia is one of the largest bilateral trade relationships in the Andean region:

Metric	Value (2025)
Total bilateral trade	~$2.8 billion
Ecuador exports to Colombia	~$1.1 billion
Colombia exports to Ecuador	~$1.7 billion
Ecuador trade deficit with Colombia	~$600 million
Shared border length	586 km
Border crossing points	3 formal, numerous informal

Ecuador's Top Imports from Colombia

Product Category	Annual Value (est.)	Tariff Impact
Processed foods	~$280 million	50% tariff
Pharmaceuticals	~$210 million	50% tariff
Chemicals/plastics	~$190 million	50% tariff
Manufactured goods	~$175 million	50% tariff
Vehicles/parts	~$150 million	50% tariff
Textiles	~$120 million	50% tariff
Paper/cardboard	~$95 million	50% tariff
Other	~$480 million	Various

Ecuador's Top Exports to Colombia

Product Category	Annual Value (est.)	Tariff Impact
Canned tuna/fish	~$220 million	50% tariff
Palm oil	~$150 million	50% tariff
Petroleum products	~$130 million	Separate OCP dispute
Agricultural goods	~$120 million	50% tariff
Processed cocoa	~$85 million	50% tariff
Wood products	~$75 million	50% tariff
Other	~$320 million	Various

OCP Pipeline Dimension

Ecuador has separately raised transport fees for the OCP Ecuador S.A. heavy crude pipeline, which transits from the Oriente oil fields to the Esmeraldas export terminal:

Pipeline Detail	OCP Ecuador
Capacity	450,000 bbl/d
Actual throughput	~130,000-150,000 bbl/d
Operators served	Private oil companies
Fee increase	Details undisclosed; industry sources report 15-25%
Owner	OCP Ecuador S.A. (consortium)

While not directly related to the Colombia tariff dispute, the timing suggests Ecuador is leveraging multiple economic pressure points. OCP Ecuador has Colombian investor participation, and the fee increase affects the economics of private oil production in Ecuador.

Credendo Risk Assessment

Credendo, the Belgian credit insurance group, published an analysis finding:

Assessment	Finding
Immediate macro impact	Minimal -- bilateral trade represents <3% of either country's GDP
Short-term political risk	Elevated -- nationalist rhetoric escalating in both countries
Medium-term trade diversion	Likely -- both countries will seek alternative suppliers
Long-term structural shift	Possible -- "new era" of Andean trade friction
Ecuador sovereign risk rating	Unchanged (Category 6/7)
Colombia sovereign risk rating	Unchanged (Category 5/7)

Credendo's key conclusion: the dispute "underlines a new era" of trade friction in the Andean region, breaking from decades of preferential treatment under the Andean Community (CAN) framework. The CAN's dispute resolution mechanisms have been bypassed entirely, with both countries acting unilaterally.

Sectoral Exposure Analysis

Most Affected Sectors in Ecuador

Sector	Exposure	Substitution Difficulty	Time to Adjust
Pharmaceuticals	High ($210M imports)	High -- regulatory approvals needed for alternatives	6-12 months
Processed foods	High ($280M imports)	Moderate -- Peru, Chile can substitute	3-6 months
Agriculture (tuna exports)	High ($220M exports)	Moderate -- redirect to other markets	3-6 months
Chemicals	Moderate ($190M)	Moderate -- Brazil, Mexico alternatives	3-9 months
Automotive	Moderate ($150M)	Low -- global supply chains	1-3 months
Textiles	Low-Moderate ($120M)	Low -- Asian alternatives available	1-3 months

Pharmaceutical Supply Chain Risk

The pharmaceutical exposure is particularly acute. Ecuador imports approximately $210 million in pharmaceutical products from Colombia annually, including:

• Generic medications -- Colombia is a regional generic manufacturing hub
• Active pharmaceutical ingredients (APIs) -- used by Ecuadorian manufacturers
• Medical devices -- diagnostic and surgical equipment
• Veterinary products -- livestock and aquaculture medications

A 50% tariff on pharmaceuticals effectively raises medication costs for Ecuador's public health system (IESS, MSP) by hundreds of millions of dollars annually.

Historical Context

This is the most significant Ecuador-Colombia trade disruption since the 2008 diplomatic crisis following Colombia's cross-border military operation against FARC in Ecuadorian territory:

Crisis	Year	Duration	Trade Impact
Angostura raid	2008	20 months (diplomatic break)	~15% bilateral trade decline
Colombian import restrictions	2014	6 months	~5% decline
Border closure (COVID)	2020-2021	12 months	~25% decline
Current tariff war	2026	Ongoing	Estimated 30-40% decline

CAN Framework Implications

Both Ecuador and Colombia are members of the Andean Community (CAN), which has a customs union framework theoretically providing for free movement of goods. The bilateral tariff war effectively violates CAN obligations, raising questions about the institution's relevance:

• CAN Secretariat has called for dialogue but has no enforcement mechanism
• Neither country has invoked CAN dispute resolution
• The Cartagena Agreement (CAN founding treaty) prohibits unilateral tariff measures between members
• Precedent suggests CAN norms are subordinate to bilateral political dynamics

What to Watch

• WTO dispute proceedings -- Colombia's formal notification could trigger a lengthy dispute panel process (12-18 months minimum)
• CAN emergency summit -- the Secretariat has proposed ministerial-level dialogue; whether both countries participate will signal resolution prospects
• Pharmaceutical supply disruptions -- any medication shortages would create political pressure for targeted exemptions
• Trade diversion patterns -- Peru, Chile, and Brazil are the most likely beneficiaries; early trade data (Q2 2026) will reveal substitution speed
• Border community impact -- the Tulcan-Ipiales corridor handles ~$500 million in annual formal cross-border trade; informal trade disruption affects 50,000+ border residents
• Third-party mediation -- the US, as a major trade partner of both countries, has not yet taken a position; any intervention would be significant

Source: Credendo